Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.395 USD | +3.15% | +1.13% | -31.03% |
05-08 | Earnings Flash (CTKB) CYTEK BIOSCIENCES Reports Q1 Revenue $44.9M, vs. Street Est of $43.6M | MT |
05-08 | Transcript : Cytek Biosciences, Inc., Q1 2024 Earnings Call, May 08, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.03% | 814M | |
+11.27% | 221B | |
+8.92% | 186B | |
+14.27% | 137B | |
+27.64% | 109B | |
+0.08% | 63.09B | |
+14.75% | 52.68B | |
+4.86% | 50.86B | |
+7.69% | 42.53B | |
+7.46% | 37.76B |
- Stock Market
- Equities
- CTKB Stock
- News Cytek Biosciences, Inc.
- Cytek Biosciences Insider Sold Shares Worth $120,600, According to a Recent SEC Filing